CELLnLIFE Inc announced that it has received Series B round of funding on May 31, 2021. The transaction included participation from Quratis Inc., GAMEVIL Inc. (KOSDAQ:A063080), QuantaMatrix Inc. (KOSDAQ:A317690).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,140 KRW | +1.72% | +9.81% | -11.16% |
1st Jan change | Capi. | |
---|---|---|
-11.16% | 50.54M | |
-1.89% | 12.56B | |
-9.59% | 7.68B | |
-1.31% | 5.29B | |
+21.82% | 5.24B | |
+0.02% | 4.57B | |
-50.89% | 3.29B | |
+6.42% | 2.6B | |
-10.02% | 2.2B | |
-8.29% | 1.79B |
- Stock Market
- Equities
- A317690 Stock
- News QuantaMatrix Inc.
- CELLnLIFE Inc announced that it has received funding from Quratis Inc., GAMEVIL Inc., QuantaMatrix Inc.